Healthcare

Practical considerations for synthetic data in healthcare market research.

GLP-1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.

When cancer specialists embrace – and when they avoid – this revolutionary drug class.

What Patients Need Next and Who Will Deliver It

Football, Pride, Digital Twins… Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.

Conducted monthly in 30 countries among around 20,000 adults for over a decade, the Ipsos What Worries the World study offers an exceptional snapshot of world opinion on pressing global issues.

The U.S. healthcare claims system is a reputable source of secondary real-world data, but what happens when the patient falls out of the system?

In this Ipsos Point of View, discover how to harness AI's speed without falling into the confidence trap.

Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.